MATALUNI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 7.865
EU - Europa 933
AS - Asia 572
SA - Sud America 8
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 9.386
Nazione #
US - Stati Uniti d'America 7.858
IT - Italia 383
SG - Singapore 277
KR - Corea 177
IE - Irlanda 153
DE - Germania 93
UA - Ucraina 89
CN - Cina 77
GB - Regno Unito 61
RU - Federazione Russa 52
FR - Francia 23
FI - Finlandia 21
SE - Svezia 19
IN - India 13
RO - Romania 10
CA - Canada 7
BR - Brasile 6
CH - Svizzera 6
TR - Turchia 5
CZ - Repubblica Ceca 4
JP - Giappone 4
KG - Kirghizistan 4
NL - Olanda 4
AU - Australia 3
HK - Hong Kong 3
IQ - Iraq 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BE - Belgio 2
CL - Cile 2
DK - Danimarca 2
ES - Italia 2
IR - Iran 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VN - Vietnam 2
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 9.386
Città #
Wilmington 2.268
Houston 1.987
Woodbridge 1.801
Chandler 283
Singapore 242
Fairfield 177
New York 145
Dublin 144
Ann Arbor 112
Medford 88
Ashburn 81
Santa Clara 74
Cambridge 73
Rome 67
Seattle 67
Dearborn 54
Jacksonville 48
Beijing 42
Lawrence 42
Milan 29
Roebling 23
Moscow 21
Piove di Sacco 19
San Diego 17
Palo Alto 14
Seoul 12
San Jose 11
Turin 10
Creede 8
Redwood City 8
Bologna 7
London 7
Verona 7
Florence 6
Lodi 6
Mülheim 6
Norwalk 6
Nuremberg 6
Istanbul 5
Kilburn 5
Menlo Park 5
Naples 5
Bergamo 4
Brno 4
Council Bluffs 4
Engelhard 4
Hounslow 4
Inverigo 4
Jinan 4
Kunming 4
Lappeenranta 4
Lausanne 4
Mountain View 4
Munich 4
Palermo 4
Paris 4
San Francisco 4
Schio 4
Vicenza 4
Viterbo 4
Andover 3
Boardman 3
Guidonia 3
Helsinki 3
Karbala 3
Nanjing 3
Salt Lake City 3
Abbiategrasso 2
Ahmedabad 2
Atlanta 2
Bengaluru 2
Berlin 2
Billings 2
Bogliasco 2
Bolzano Vicentino 2
Brussels 2
Burnaby 2
Capaccio 2
Carugate 2
Castelfidardo 2
Chengdu 2
Chiswick 2
Delhi 2
Desio 2
Edmond 2
Essen 2
Falls Church 2
Gunzenhausen 2
Hefei 2
Ho Chi Minh City 2
Hong Kong 2
La Spezia 2
La Veta 2
Lissone 2
Littleton 2
Los Angeles 2
Modena 2
Montemesola 2
Montréal 2
Muenster 2
Totale 8.197
Nome #
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 425
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 418
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 404
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 400
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 395
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 392
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 381
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 381
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 370
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 362
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 338
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 335
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 330
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 322
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 317
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 287
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 279
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 276
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 259
Regional variation of Guillain-Barré syndrome 246
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 221
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 221
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 212
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 210
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 155
Current treatment practice of Guillain-Barré syndrome 118
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 118
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 108
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 106
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 106
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 101
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 63
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 63
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 61
The neurophysiological lesson from the Italian CIDP database 54
Anti-HBs titers are not decreased after treatment with oral cladribine in patients with multiple sclerosis vaccinated against hepatitis B virus 54
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 53
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 45
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 44
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 40
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 38
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 36
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 32
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 31
Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod 30
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 30
Response to Dr. Wee 28
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 27
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 27
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 26
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 26
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 26
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 23
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 22
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 21
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 21
Impact of environmental factors and physical activity on disability and quality of life in CIDP 20
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 15
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 12
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial 11
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 10
null 3
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 1
Totale 9.586
Categoria #
all - tutte 25.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.654 0 0 0 187 191 226 172 175 220 170 153 160
2020/20211.575 151 151 150 171 231 197 204 148 52 36 62 22
2021/2022443 28 35 13 38 24 42 13 19 37 40 28 126
2022/2023925 55 60 120 140 67 167 93 44 84 5 66 24
2023/2024394 68 12 27 22 32 62 29 11 24 22 3 82
2024/2025574 47 314 163 50 0 0 0 0 0 0 0 0
Totale 9.586